The global heart-lung machine market size is anticipated to reach USD 3.67 billion by 2033, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 6.36% from 2026 to 2033. The cardiopulmonary bypass (CPB) machine, also known as a heart-lung machine, plays a significant role in open heart surgeries, including procedures to address Cardiovascular Diseases (CVDs). It temporarily takes over the functions of the heart and lungs, allowing surgeons to operate on a still heart while maintaining blood circulation and oxygenation.
According to the World Health Organization (WHO), CVDs are one of the primary causes of global mortality, resulting in an estimated 17.9 million deaths annually. In the U.S., heart disease is the leading cause of death for both men and women. Moreover, the high prevalence of heart disease leads to an increased demand for a wide range of cardiovascular surgeries, such as open heart, with approximately 500,000 surgeries performed annually. The cardiopulmonary bypass (CPB) machine market is growing due to rising cardiovascular surgeries and advancements in surgical techniques and technologies. As a result, the CPB machine market is experiencing growth due to its crucial role in cardiac surgery.
Request a free sample copy or view report summary: Heart-lung Machine Market Report
In 2025, the coronary artery bypass grafting (CABG) segment held the largest share, accounting for 31.56% of the CPB machine market. The increasing prevalence of CVDs and the growing demand for bypass surgeries drive the growth of the CABG segment.
In 2025, the hospital segment held the largest share of 81.07% in the CPB machine market. This dominance is driven by factors such as the increasing prevalence of CVDs, advancements in surgical procedures, and the growing demand for cardiac surgeries. In addition, the aging population plays a significant role in market growth, as it is more susceptible to heart valve diseases and other cardiovascular conditions.
In 2025, North America held the dominant share of 52.06% in the CPB machine market. This significant market share is primarily attributed to factors such as a high incidence of heart disease, a sizable aging population, and a strong healthcare infrastructure. These factors collectively contributed to the growth of the North American region.
Grand View Research has segmented the global heart-lung machine market report based on product, application, end use, and region:
Heart-lung Machine Product Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
Capital Equipment
Pumps
Heater-Cooler Units / Heat Exchange Systems
Monitoring Systems
Others
Consumables
Cannulas
By Product
Arterial Cannulas
Venous Cannulas
Cardioplegia Cannulas
Vent Cannulas
ECMO Cannulas
By Age Group
Adult
Pediatric
Oxygenators
By Product
Membrane Oxygenators
ECMO Oxygenators
Pediatric/Neonatal Oxygenators
Other Oxygenators
By Age Group
Adult
Pediatric
Blood Reservoirs & Filtration Systems
Tubing Sets & Circuits
Accessories & Consumables
Heart-lung Machine Application Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
Coronary Artery Bypass Grafting (CABG)
Heart Valve Surgeries
Heart Transplant
Lung Transplant
Others
Heart-lung Machine End Use Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
Public Healthcare Institutions
Private Healthcare Institutions
Heart-lung Machine Regional Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
Spain
Italy
France
Denmark
Norway
Sweden
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Chile
Colombia
Argentina
Middle East and Africa
South Africa
Saudi Arabia
UAE
Kuwait
List Of Key Players in the Heart-lung Machine Market
Medtronic
Terumo Corporation
LivaNova PLC
Getinge AB
Braille Biomedical
Nipro Corporation do Brasil (NIPRO)
Surge Cardiovascular
EUROSETS
Technowood America Corporation
Fresenius Medical Care
MERA (Senko Medical Instrument Mfg. Co., Ltd.)
"The quality of research they have done for us has been excellent..."